Detection of histological type and genetic mutation in lung cancer using ion mobility spectrometry - Diagnosis of lung cancer using IMS

St. Marianna University School of Medicine Division of Respiratory and Infectious Diseases, Department of Internal Medicine0 sites30 target enrollmentJuly 3, 2012

ConditionsTo investigate if IMS can diagnosis histological type and genetic mutation using volatile organic compounds (VOCs) in patients with lung cancer.

Overview

Phase: 未知
Intervention: Not specified
Conditions: To investigate if IMS can diagnosis histological type and genetic mutation using volatile organic compounds (VOCs) in patients with lung cancer.
Sponsor: St. Marianna University School of Medicine Division of Respiratory and Infectious Diseases, Department of Internal Medicine
Enrollment: 30
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

July 3, 2012

End Date

May 1, 2014

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

St. Marianna University School of Medicine Division of Respiratory and Infectious Diseases, Department of Internal Medicine

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\) To refuse to give informed consent 2\) Lung cancer of unknown histological type 3\) Patients with no diagnosis of lung cancer 4\) Patients who are pregnant, possibly pregnant, or lactating. 5\) Patients with renal failure. (serum creatinine \> 2\.0 mg/dL, BUN \> 30mg/dl) 6\) AST or ALT \> 100IU 7\) Patients with severe diabetes, hyperlipidemia or hyperuricemia 8\) Patients who are judged inappropriate by the doctor in charge.